Paulo Cesar Ribeiro Barbosa1, Rick J Strassman2, Dartiu Xavier da Silveira3, Kelsy Areco3, Robert Hoy2, Jessica Pommy2, Robert Thoma2, Michael Bogenschutz4. 1. University of New Mexico Center for Psychiatric Research, 1101 Yale Blvd NE, Albuquerque, NM 87106, USA; Departamento de Filosofia e Ciências Humanas, Universidade Estadual de Santa Cruz, Campus Soane Nazaré de Andrade, Rodovia Jorge Amado, km 16, Bairro Salobrinho, Ilhéus, BA CEP 45662-900, Brazil. Electronic address: pcrbarbosa@uesc.br. 2. University of New Mexico Center for Psychiatric Research, 1101 Yale Blvd NE, Albuquerque, NM 87106, USA. 3. Departamento de Psiquiatria da Universidade Federal de São Paulo, Rua Borges Lagoa, n° 570, São Paulo, SP CEP 04038-020, Brazil. 4. University of New Mexico Center for Psychiatric Research, 1101 Yale Blvd NE, Albuquerque, NM 87106, USA; New York School of Medicine, 550 1st Avenue, New York, NY 10016, USA.
Abstract
BACKGROUND: Hoasca (also called ayahuasca) is a N,N-dimethyltryptamine (DMT) - containing psychedelic brew originally used for magico-religious purposes by Amerindian populations of the Amazon Basin. Recently, Brazilian syncretic churches have helped spread the ritual use of hoasca to Western societies. The aim of this study was to evaluate substance use, and neuropsychological and psychological functioning of regular hoasca users within a religious setting. METHODS: Assessment of socio-economic status, mood, personality traits, impulsiveness, drug use, quality of life, extrinsic and intrinsic religiosity, and neuropsychological function was performed on 30 volunteers from a U.S. branch of União do Vegetal (UDV), a Brazilian religion which uses hoasca ritually. We also assessed 27 non-hoasca-using control subjects matched by socio-demographic profile and church attendance. Mann-Whitney U, chi-squared and Fisher tests were used to analyze differences between groups. Spearman's association and simple logistic regression tests were used to analyze the impact of frequency of hoasca use on dependent variables. RESULTS: Relative to the control group, the UDV group demonstrated lower scores for depression (p=0.043, r=.27) and confusion (p=0.032, r=.29) as assessed by the Profile of Mood States (POMS); higher scores on the instrument Big Five Inventory (BFI) for the personality traits agreeableness (p=0.028, r=.29) and openness (p=0.037, r=.28); higher scores on the quality life domain role limitations due to physical health as determined by the instrument Medical Outcomes Study Short Form-36 - SF-36 (p=0.035, r=.28); less recent use of alcohol (p<0.001, φc=.57), greater past use of alcohol to intoxication (p=0.007, φc=.36) and past use of cannabis (p=0.001, φc=.45) as measured by the Addiction Severity Index (ASI), 5th edition; better score on a measure of memory vulnerability to proactive interference as measured by the California Verbal Learning Test - CVLT (p=0.040, r=.27). Lifetime use of hoasca was positively correlated with role limitations due to physical health (p=0.032, rs=.39) and negatively associated with lifetime heavy alcohol use (p=0.034, OR=0.979). CONCLUSIONS: The findings indicate that religious use of hoasca does not adversely affect neuropsychological functioning and may have positive effects on substance abuse and mood.
BACKGROUND: Hoasca (also called ayahuasca) is a N,N-dimethyltryptamine (DMT) - containing psychedelic brew originally used for magico-religious purposes by Amerindian populations of the Amazon Basin. Recently, Brazilian syncretic churches have helped spread the ritual use of hoasca to Western societies. The aim of this study was to evaluate substance use, and neuropsychological and psychological functioning of regular hoasca users within a religious setting. METHODS: Assessment of socio-economic status, mood, personality traits, impulsiveness, drug use, quality of life, extrinsic and intrinsic religiosity, and neuropsychological function was performed on 30 volunteers from a U.S. branch of União do Vegetal (UDV), a Brazilian religion which uses hoasca ritually. We also assessed 27 non-hoasca-using control subjects matched by socio-demographic profile and church attendance. Mann-Whitney U, chi-squared and Fisher tests were used to analyze differences between groups. Spearman's association and simple logistic regression tests were used to analyze the impact of frequency of hoasca use on dependent variables. RESULTS: Relative to the control group, the UDV group demonstrated lower scores for depression (p=0.043, r=.27) and confusion (p=0.032, r=.29) as assessed by the Profile of Mood States (POMS); higher scores on the instrument Big Five Inventory (BFI) for the personality traits agreeableness (p=0.028, r=.29) and openness (p=0.037, r=.28); higher scores on the quality life domain role limitations due to physical health as determined by the instrument Medical Outcomes Study Short Form-36 - SF-36 (p=0.035, r=.28); less recent use of alcohol (p<0.001, φc=.57), greater past use of alcohol to intoxication (p=0.007, φc=.36) and past use of cannabis (p=0.001, φc=.45) as measured by the Addiction Severity Index (ASI), 5th edition; better score on a measure of memory vulnerability to proactive interference as measured by the California Verbal Learning Test - CVLT (p=0.040, r=.27). Lifetime use of hoasca was positively correlated with role limitations due to physical health (p=0.032, rs=.39) and negatively associated with lifetime heavy alcohol use (p=0.034, OR=0.979). CONCLUSIONS: The findings indicate that religious use of hoasca does not adversely affect neuropsychological functioning and may have positive effects on substance abuse and mood.
Authors: Lucas Silva Rodrigues; Giordano Novak Rossi; Juliana Mendes Rocha; Flávia L Osório; José Carlos Bouso; Jaime E Cecílio Hallak; Rafael G Dos Santos Journal: Eur Arch Psychiatry Clin Neurosci Date: 2021-04-29 Impact factor: 5.270
Authors: Will Lawn; Jaime E Hallak; Jose A Crippa; Rafael Dos Santos; Lilla Porffy; Monica J Barratt; Jason A Ferris; Adam R Winstock; Celia J A Morgan Journal: Sci Rep Date: 2017-11-09 Impact factor: 4.379
Authors: D Erritzoe; L Roseman; M M Nour; K MacLean; M Kaelen; D J Nutt; R L Carhart-Harris Journal: Acta Psychiatr Scand Date: 2018-06-19 Impact factor: 6.392
Authors: Paulo Cesar Ribeiro Barbosa; Luís F Tófoli; Michael P Bogenschutz; Robert Hoy; Lais F Berro; Eduardo A V Marinho; Kelsy N Areco; Michael J Winkelman Journal: Front Psychiatry Date: 2018-04-24 Impact factor: 4.157
Authors: Elisangela G Cata-Preta; Yasmim A Serra; Eliseu da C Moreira-Junior; Henrique S Reis; Natali D Kisaki; Matheus Libarino-Santos; Raiany R R Silva; Thaísa Barros-Santos; Lucas C Santos; Paulo C R Barbosa; José L Costa; Alexandre J Oliveira-Lima; Lais F Berro; Eduardo A V Marinho Journal: Front Pharmacol Date: 2018-05-29 Impact factor: 5.810
Authors: Joaquim Soler; Matilde Elices; Elisabeth Dominguez-Clavé; Juan C Pascual; Amanda Feilding; Mayte Navarro-Gil; Javier García-Campayo; Jordi Riba Journal: Front Pharmacol Date: 2018-03-20 Impact factor: 5.810